Latest News about IBB
Recent news which mentions IBB
   Bull vs. Bear: How Healthy Are Biotech ETFs?
   
  
  
  May 10, 2023
  From ETF Trends
 
   ImmunoGen stock rockets after ovarian cancer treatment shows ‘meaningful’ survival benefit
   
  
  
  May 03, 2023
  From MarketWatch
 
   VettaFi Voices On: Smart Beta and Equal-Weight ETFs
   
  
  
  April 28, 2023
  From ETF Trends
 
   Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
   
  
  
  April 13, 2023
  From Benzinga
 
   Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
   
  
  
  April 13, 2023
  From Benzinga
 
   New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
   
  
  
  April 12, 2023
  From Benzinga
 
   Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
   
  
  
  April 11, 2023
  From Benzinga
 From Benzinga
 From Benzinga
 
   Here’s one for the battered bulls: the second-largest sector in the S&P 500 is stirring to life, says this strategist.
   
  
  
  March 22, 2023
  From MarketWatch
 
   US Judge Weighs Nationwide Ban On Abortion Pills
   
  
  
  March 16, 2023
  From Benzinga
 From InvestorPlace
 
   Silicon Valley Bank Meltdown Hits Healthcare Sector As Well
   
  
  
  March 13, 2023
  From Benzinga
 
   Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
   
  
  
  March 10, 2023
  From Benzinga
 
   FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
   
  
  
  March 10, 2023
  From Benzinga
 From Benzinga
 
   Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
   
  
  
  March 07, 2023
  From Benzinga
 
   FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
   
  
  
  March 01, 2023
  From Benzinga
 
   The stock market’s January rally was real, and these stocks and ETFs can help you ride the next leg up
   
  
  
  February 22, 2023
  From MarketWatch
 From InvestorPlace
 From Benzinga
 
   The 3 Best Biotech Stocks Under $1 to Buy for January
   
  
  
  January 26, 2023
  From InvestorPlace
 From Benzinga
 From Benzinga
 
   Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
   
  
  
  December 27, 2022
  From Benzinga
 
   What the end of the stock market’s ‘FANG-era’ means for ETFs
   
  
  
  December 22, 2022
  From MarketWatch
 
   Look to SBIO for Biotech Exposure
   
  
  
  December 12, 2022
  From ETF Trends
 From Benzinga
 
   Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors
   
  
  
  December 02, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
